Allogenic stem cell transplantation for children with advanced MDS:: results from the EWOG-MDS study group employing a pre-transplant preparative regimen with busulfan, cyclophosphamide and melphalan

被引：0
|
作者：
Niemeyer, CM
Zecca, M
Korthoff, E
Duffner, U
Zintl, F
Ebell, W
Stary, J
Dillo, D
Bader, P
Peters, C
Schmugge, M
Sedlacek, P
van Heuvel, M
Bergsträsser, E
Trebo, M
Nölke, P
Locateffl, F
机构：
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 44 条
  • [1] Allogeneic stem cell transplantation for children with advanced primary MDS: Results from the EWOG-MDS study group employing a pre-transplant preparative regimen with busulfan, cyclophosphamide and melphalan.
    Niemeyer, CM
    Zecca, M
    Korthoff, E
    Duffner, U
    Zintl, F
    Ebell, W
    Stary, J
    Dilloo, D
    Peters, C
    Schmugge, M
    Sedlacek, P
    Messina, C
    van Heuvel, M
    Bergstraesser, E
    Trebo, M
    Noellke, P
    Locatelli, F
    BLOOD, 2004, 104 (11) : 632A - 632A
  • [2] Busulfan, cyclophosphamide and melphalan as preparative regimen to allogeneic stem cell transplantation in childhood MDS:: results of the second interim analysis of the EBMT/EWOG-MDS study
    Locatelli, F
    Zecca, M
    Zintl, F
    Nürnberger, W
    Ebell, W
    Niethammer, D
    Stary, J
    Bender-Götze, S
    Ortega, J
    Egeler, M
    Duffner, U
    Dini, G
    Souillet, G
    Giorgiani, G
    Messina, C
    Noellke, P
    van Wering, E
    Niemeyer, C
    BONE MARROW TRANSPLANTATION, 2001, 27 : S69 - S70
  • [3] Haematopoietic stem cell transplantation for advanced primary MDS in children: results of the EWOG-MDS study group
    Strahm, B.
    Locatelli, F.
    Beck, J.
    Bergstraesser, E.
    Bierings, M.
    Chybicka, A.
    Ebell, W.
    Korthoff, E.
    Schmugge, M.
    Sedlacek, P.
    Stary, J.
    Matthes, S.
    van den Heuvel-Eibrink, M.
    Wojcik, D.
    Zecca, M.
    Fischer, A.
    Noellke, P.
    Niemeyer, C. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 61 - 61
  • [4] Hematopoietic stem cell transplantation for advanced primary MDS in children:: results of a retrospective analysis from the EWOG-MDS group
    Zecca, M.
    Noellke, P.
    Fischer, A.
    Bader, P.
    Bernardo, M. E.
    Bergstrasser, E.
    Hasle, H.
    van den Heuvel, M.
    Kabisch, H.
    Korthof, E.
    Stary, J.
    Strahm, B.
    Trebo, M.
    Zintl, F.
    Locatelli, F.
    Niemeyer, C.
    LEUKEMIA RESEARCH, 2007, 31 : S38 - S39
  • [5] Busulfan, cyclophosphamide and melphalan as pretransplant conditioning regimen for children with MDS and juvenile myelomonocytic leukemia:: Interim analysis of the EWOG-MDS/EBMT prospective study
    Locatelli, F
    Zecca, M
    Duffner, U
    Bender-Götze, C
    Dini, G
    Ebell, W
    Hoogerbrugge, PM
    Klingebiel, T
    Kremens, B
    Messina, C
    Nölke, P
    Nürnberger, W
    Pession, A
    Peters, C
    Soulliet, G
    Stary, G
    Uderzo, C
    Zimmermann, M
    Zintl, F
    LEUKEMIA, 2000, 14 (05) : 971 - 971
  • [6] Haematopoietic stem cell transplantation for advanced primary MDS in children: results of the EWOG MDS study group
    Strahm, B.
    Locatelli, F.
    Beck, J.
    Bergstraesser, E.
    Bierings, M.
    Chybicka, A.
    Ebell, W.
    Korthoff, E.
    Scmugge, M.
    Sedlacek, P.
    Stary, J.
    Matthes, S.
    van der Heuvel-Eibrink, M.
    Wojcik, D.
    Zecca, M.
    Fischer, A.
    Noellke, P.
    Niemeyer, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S76 - S76
  • [7] Hematopoietic stem cell transplantation following a Treosulfan based preparative regimen for children with myelodysplastic syndrome: preliminary results of a EWOG-MDS study
    Strahm, B.
    Albert, M.
    Bader, P.
    Dworzak, M.
    Stary, J.
    Masetti, R.
    Matthes-Martin, S.
    Sedlacek, P.
    Sykora, K. W.
    Vraetz, T.
    Locatelli, F.
    Niemeyer, C.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S39 - S39
  • [8] Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study
    Strahm, B.
    Noellke, P.
    Zecca, M.
    Korthof, E. T.
    Bierings, M.
    Furlan, I.
    Sedlacek, P.
    Chybicka, A.
    Schmugge, M.
    Bordon, V.
    Peters, C.
    O'Marcaigh, A.
    de Heredia, C. D.
    Bergstraesser, E.
    Moerloose, B. D.
    van den Heuvel-Eibrink, M. M.
    Stary, J.
    Trebo, M.
    Wojcik, D.
    Niemeyer, C. M.
    Locatelli, F.
    LEUKEMIA, 2011, 25 (03) : 455 - 462
  • [9] Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study
    B Strahm
    P Nöllke
    M Zecca
    E T Korthof
    M Bierings
    I Furlan
    P Sedlacek
    A Chybicka
    M Schmugge
    V Bordon
    C Peters
    A O'Marcaigh
    C D de Heredia
    E Bergstraesser
    B D Moerloose
    M M van den Heuvel-Eibrink
    J Starý
    M Trebo
    D Wojcik
    C M Niemeyer
    F Locatelli
    Leukemia, 2011, 25 : 455 - 462
  • [10] Busulfan (BU), cyclophosphamide (CY) and melphalan (L-PAM) as pre-transplant conditioning regimen for children with bids and juvenile myelomonocytic leukemia:: Interim analysis of the EWOG-MDS/EBMT prospective study.
    Locatelli, F
    Zecca, M
    Duffner, U
    Bender-Götze, C
    Dini, G
    Ebell, W
    Hoogerbrugge, PM
    Klingebiel, T
    Kremens, B
    Messina, C
    Nölke, P
    Nürnberger, W
    Pession, A
    Peters, C
    Soulliet, G
    Stary, J
    Uderzo, C
    Zimmermann, M
    Zintl, F
    Niemeyer, C
    BLOOD, 1999, 94 (10) : 350A - 350A
12345